A nonclinical safety and pharmacokinetic evaluation of N6022: A first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma
Dorothy B. Colagiovanni, Daniel W. Drolet, Emilie Langlois-Forget, Marie-Pier Piché, Doug Looker, Gary J. RosenthalVolume:
62
Year:
2012
Language:
english
Pages:
10
DOI:
10.1016/j.yrtph.2011.12.012
File:
PDF, 680 KB
english, 2012